Cargando…

The KCNE genes in hypertrophic cardiomyopathy: a candidate gene study

BACKGROUND: The gene family KCNE1-5, which encode modulating β-subunits of several repolarising K(+)-ion channels, has been associated with genetic cardiac diseases such as long QT syndrome, atrial fibrillation and Brugada syndrome. The minK peptide, encoded by KCNE1, is attached to the Z-disc of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hedley, Paula L, Haundrup, Ole, Andersen, Paal S, Aidt, Frederik H, Jensen, Morten, Moolman-Smook, Johanna C, Bundgaard, Henning, Christiansen, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204304/ https://www.ncbi.nlm.nih.gov/pubmed/21967835 http://dx.doi.org/10.1186/1477-5751-10-12

Ejemplares similares

MT-CYB mutations in hypertrophic cardiomyopathy
por: Hagen, Christian M, et al.
Publicado: (2013)

MT-CYB mutations in hypertrophic cardiomyopathy
por: Hagen, Christian M, et al.
Publicado: (2013)

Mitochondrial Haplogroups Modify the Risk of Developing Hypertrophic Cardiomyopathy in a Danish Population
por: Hagen, Christian M., et al.
Publicado: (2013)

Private Mitochondrial DNA Variants in Danish Patients with Hypertrophic Cardiomyopathy
por: Hagen, Christian M., et al.
Publicado: (2015)

A Novel Myosin Essential Light Chain Mutation Causes Hypertrophic Cardiomyopathy with Late Onset and Low Expressivity
por: Andersen, Paal Skytt, et al.
Publicado: (2012)

Race and gender representation of hypertrophic cardiomyopathy or long QT syndrome cases in a South African research setting
por: Heradien, M, et al.
Publicado: (2007)

Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy
por: van der Merwe, Lize, et al.
Publicado: (2008)

Abnormal blood pressure response to exercise occurs more frequently in hypertrophic cardiomyopathy patients with the R92W troponin T mutation than in those with myosin mutations
por: Heradien, Marshall, et al.
Publicado: (2009)

Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy
por: Mouton, Jomien M, et al.
Publicado: (2015)

Striving towards the ideal cardiac functional assessment strategy: the contribution of tissue Doppler, strain and strain rate imaging
por: Moolman-Smook, JC, et al.
Publicado: (2007)

Differential Association between HERG and KCNE1 or KCNE2
por: Um, Sung Yon, et al.
Publicado: (2007)

The KCNE Tango – How KCNE1 Interacts with Kv7.1
por: Wrobel, Eva, et al.
Publicado: (2012)

Arrhythmogenic KCNE gene variants: current knowledge and future challenges
por: Crump, Shawn M., et al.
Publicado: (2014)

Mendelian-inherited heart disease: a gateway to understanding mechanisms in heart disease Update on work done at the University of Stellenbosch
por: Brink, PA, et al.
Publicado: (2009)

Differential Modulations of KCNQ1 by Auxiliary Proteins KCNE1 and KCNE2
por: Li, Pan, et al.
Publicado: (2014)

Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes
por: Ingles, Jodie, et al.
Publicado: (2019)

Dysfunctional Network and Mutation Genes of Hypertrophic Cardiomyopathy
por: Cui, Yunwen, et al.
Publicado: (2022)

Probing the structural basis for differential KCNQ1 modulation by KCNE1 and KCNE2
por: Wang, Yuhong, et al.
Publicado: (2012)

Regulation of human cardiac potassium channels by full-length KCNE3 and KCNE4
por: Abbott, Geoffrey W.
Publicado: (2016)

Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene
por: Ehlermann, Philipp, et al.
Publicado: (2008)

Gene database for the development of genetic testing for hypertrophic cardiomyopathy
por: Silas, Justin Carlus, et al.
Publicado: (2014)

An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy
por: Tudurachi, Bogdan-Sorin, et al.
Publicado: (2023)

Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry
por: Veselka, Josef, et al.
Publicado: (2020)

Prevention of sudden cardiac death in hypertrophic cardiomyopathy: Risk assessment using left atrial diameter predicted from left atrial volume
por: Mills, Helen, et al.
Publicado: (2020)

KCNE1 and KCNE3 Stabilize and/or Slow Voltage Sensing S4 Segment of KCNQ1 Channel
por: Nakajo, Koichi, et al.
Publicado: (2007)

KCNE1 divides the voltage sensor movement in KCNQ1/KCNE1 channels into two steps
por: Barro-Soria, Rene, et al.
Publicado: (2014)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Identification of MYOM2 as a candidate gene in hypertrophic cardiomyopathy and Tetralogy of Fallot, and its functional evaluation in the Drosophila heart
por: Auxerre-Plantié, Emilie, et al.
Publicado: (2020)

Identification of variants in genes associated with hypertrophic cardiomyopathy in Mexican patients
por: García-Vielma, Catalina, et al.
Publicado: (2023)

Symmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus
por: Langhorn, R., et al.
Publicado: (2017)

Analyses of more than 60,000 exomes questions the role of numerous genes previously associated with dilated cardiomyopathy
por: Nouhravesh, Nina, et al.
Publicado: (2016)

Pathologic grooming (acne excoriee, trichotillomania, and nail biting) in 4 generations of a single family
por: Khumalo, Nonhlanhla P., et al.
Publicado: (2016)

Long-QT mutations in KCNE1 modulate the 17β-estradiol response of Kv7.1/KCNE1
por: Erlandsdotter, Lisa-Marie, et al.
Publicado: (2023)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Disopyramide for Hypertrophic Cardiomyopathy
por: Sanchez-Nadales, Alejandro, et al.
Publicado: (2019)

The Influence of Angiotensin Converting Enzyme and Angiotensinogen Gene Polymorphisms on Hypertrophic Cardiomyopathy
por: Luo, Rong, et al.
Publicado: (2013)

Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage
por: Viswanathan, Shiv Kumar, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mo2otcpbdmstjg5ic2iju6vmmm